Application note: Direct and Competitive Live Cell Antibody Binding
Utilizing Advanced High-Throughput Flow Cytometry to Quantify Direct and Competitive Live Cell Antibody Binding
List view / Grid view
Utilizing Advanced High-Throughput Flow Cytometry to Quantify Direct and Competitive Live Cell Antibody Binding
A novel peptide can suppress MYC by binding directly to it with sub-micro-molar affinity, advancing cancer drug development.
Explore cutting-edge hit-to-lead insights through exclusive interviews and studies by leading experts in the field.
The first complete control map for any protein has been made for KRAS, and four potential drug targets have been discovered.
Proximity labelling and single-particle tracking demonstrated that effectors in bacteria bind to mobile injectisome components.
A new strategy enables researchers to be more precise in the control of gene expression of a therapeutic protein.
A new finding that pathological alpha-synuclein causes cells to increase protein synthesis suggests new targets for treating PD.
New software can make protein molecules that bind with high affinity and specificity to many biomarkers, including human hormones.
A discovery about Zika’s enzyme, NS2B-NS3, offers promise for therapeutic targets for Zika and other flaviviruses.
In this eBook, discover how to better understand tissue landscapes with different microscopy techniques including multiplex imaging.
Using saturation genome editing, researchers have created a map of disease-causing mutations for neurodevelopmental disorders and cancer.
A discovery about the mutated protein DECTIN-1, that limits the production of T regulatory cells, could lead to more effective drugs.
New findings about how RBM10 inhibits lung cancer growth offers potential for an anti-cancer drug and more personalised treatment.
A signalling mechanism for ventricular fibrillation involving the stress kinases p38γ and p38δ has been discovered.
Findings of rare CRISPR-linked gene modules and a novel CRISPR-Cas system have promising implications for genomic therapeutics.